Project Details
Description
An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus
| Status | Active |
|---|---|
| Effective start/end date | 9/17/20 → 9/30/25 |
Funding
- ARGENX
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.